期刊文献+

化疗与序贯放化疗治疗鼻型结外NK/T细胞淋巴瘤的疗效比较 被引量:2

Curative effect of nasal type extranodal NK/T-cell lymphoma by sequential chemotherapy combined radiotherapy compared with chemotherapy
原文传递
导出
摘要 目的:探讨化疗与序贯放化疗治疗鼻型结外NK/T细胞淋巴瘤的疗效。方法:57例经病理形态学及免疫组织化学检查确诊的鼻型结外NK/T细胞淋巴瘤患者,随机分为化疗组和放化疗组。化疗组23例患者交替应用CHOP方案、VDLP方案和MEOP方案各2个疗程后进入临床观察;放化疗组34例患者除上述化疗外,均应用直线加速器进行原发部位的三维适形放疗。结果:①治疗结束时,化疗组治疗总有效率为87.0%,放化疗组总有效率为91.2%,2组差异无统计学意义(P>0.05);②2组患者随访1年的总有效率分别为73.9%和76.5%,2组仍无明显差异(P>0.05);③2组患者随访3年和5年的无病生存率分别为61.3%,47.6%和43.5%,21.4%,差异均有统计学意义(P<0.05);④治疗模式与长期生存密切相关;⑤发热、消瘦、盗汗等全身症状、中晚期(Ⅲ、Ⅳ期)、国际预后指数、功能状态评分均与预后相关,且均为独立的预后因素。结论:序贯放化疗治疗鼻型结外NK/T细胞淋巴瘤较单纯化疗疗效明显,可以显著改善长期生存率。 Objective:To explore the curative effect of nasal type extranodal NK/T-cell lymphoma by sequen- tial chemotherapy combined radiotherapy compared with chemtherapy. Method: Fifty-seven cases of nasal type ex- tranodal NK/T-cell lymphoma confirmed by pathological morphology and immuno-histochemistry were divided into chemotherapy combined radiotherapy group(34 cases) or chemotherapy group(23 cases). Twenty-three patients in the chemotherapy group alternately applied CHOP, VDLP and MEOP regimen after each two treatments into the clinical observation; Chemotherapy combined radiotherapy group of 34 patientsm, in addition to the above chemo- therapy, applied three-dimensional conformal radiation therapy of the primary site by linear accelerators. Then all of patients were ceased treatment and followed up 3--5 years. Result: ①After treatment, effective rate of two groups was 91.2 % and 87, 0 %, there was no obvious difference(P〉0.05) ;②After follow up about 1 year, effective rate of two groups was 76.5% and 73.9%, there was no obvious difference(P〉0.05) ;③After follow up a- bout 3 years and 5 years, disease free survival(DFS) of two groups was 61.3% ,47.6% and 43.5% ,21.4%, there was obvious difference(P〈0.05). ④ Long-term survival is closely related to treatment mode. ⑤B symptoms, ad- vanced (Ⅲ , IV) stage, the International Prognostic Index(IPI), KPS scores were correlated with prognosis, and were independent prognostic factors. Conclusion:Treatment with chemotherapy and radiotherapy for nasal type ex- tranodal NK/T-cell lymphoma had obvious curative effect and may improve long-term survival efficiently compared with chemothera!~v alone.
出处 《临床耳鼻咽喉头颈外科杂志》 CAS 北大核心 2013年第23期1283-1286,1290,共5页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
关键词 鼻肿瘤 化疗 放疗 疗效 nose neoplasms chemotherapy radiotherapy curative effect
  • 相关文献

参考文献19

  • 1OSHIMI K. Leukemia and lymphoma of natural killer lineage cells[J]. Int JHematol,2003,78 : 18--23.
  • 2BARRIONUEVO C, ZAHARIA M, MARTINEZ M T, et al. Extranodat NK/T-cell lymphoma, nasal type: study of clinicopathologic and prognosis factors in a series of 78 cases from Peru[J]. Appl Immnohis- tochem Mol Morphol, 2007,15: 38-- 44.
  • 3LIU A,NAKATSUKAS,YANGW I,et al. Expres sion of cell adhesion molecules and chemokine recep tors: angioinvasiveness in in nasal NK/T-cell lympho ma[J]. Oncol Rep,2005,13:613--620.
  • 4WU X,LI P,ZHAO J,et al. A clinical study of 115 patients with ex-tranodal natural killer/T-cell lympho- ma, nasaltype[J]. ClinOncol,2008,20:619--625.
  • 5KOY H,CHOEY,KIMJ E,etal. NK and NKlike T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status[J]. Histopathology, 2004,44 : 480-- 489.
  • 6KIM S J,KIM B S,CHOI C W,et al. Ki-67 expres- sion is predictive of prognosis in patients with stage I/ II extranodal NK/T-cell lymphoma, nasal type [J]. Ann Oncol,2007,18 : 1382-- 1387.
  • 7SHIM S J ,YANG W I,SHIN E,et al. Clinical signifi- cance of cyclooxy-genase-2 expression in extranodal natural killer(NK) /T-cell lymphoma, nasal type[J]. Int J Radiat Oncol Biol Phys,2007,67:31 -38.
  • 8SAVAGE K J,CHHANABHAI M, GASCOYNE R D,et al. Characterization of peripheral T cell lympho mas in a single North American institution by the WHO classification[J]. Ann Oncol, 2004,15:1 467- 1475.
  • 9王海,张曙,石群立.鼻型NK/T细胞淋巴瘤研究进展[J].中华肿瘤防治杂志,2008,15(24):1909-1913. 被引量:29
  • 10阮寒光,邬蒙.鼻腔NK/T细胞淋巴瘤60例临床治疗和预后分析[J].实用癌症杂志,2009,24(3):291-293. 被引量:16

二级参考文献45

  • 1姜余梅,刘卫平,唐琼兰,李甘地,郭嘉,廖殿英.鼻NK/T细胞淋巴瘤瘤细胞分化状态的探讨[J].中华病理学杂志,2003,32(5):437-439. 被引量:19
  • 2杨拴盈,张王刚,赵新汉,张晓智,吴保俊,王中卫,王双妮.鼻型NK/T细胞淋巴瘤临床病理特征及预后分析[J].现代肿瘤医学,2005,13(3):349-351. 被引量:4
  • 3潘战和,黄慧强,林旭滨,夏云飞,夏忠军,彭玉龙,蔡清清,林桐榆,姜文奇,管忠震.鼻型NK/T细胞非霍奇金淋巴瘤预后因素探讨(附93例长期随访结果分析)[J].癌症,2005,24(12):1493-1497. 被引量:24
  • 4王碧芸,洪小南,印季良,陆洪芬,李小秋,马学军,郭晔.鼻腔NK/T细胞淋巴瘤的预后因素分析[J].中华肿瘤杂志,2006,28(7):523-525. 被引量:14
  • 5Gwi Eon Kim, Woong Sub Koom, Woo-lck Yang, et al. Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis[ J ]. Head & Neck ,2004,26 (7) :584 - 593.
  • 6Kim WS,Song SY,Ahn YC,et al. CHOP followed by involved field radiation:Is it optimal for localized nasal natural killer/T-cell lymphoma? [J]. Ann Oncol,2001,12(3) :349 -352.
  • 7Cheung MMC,Chan JKC ,Lau WH,et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx:Climical features ,tumor immunophenotype,and treatment outcome in 113 patients[J]. J Clin Oncol, 1998,16(1) :70 -77.
  • 8Kim GE, Lee SW, Chang SK, et al. Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentrie lymphoma of the head and neck [ J ]. Radiother Oncol, 2001,61 ( 3 ) : 261 - 269.
  • 9Tao Q,Ho FC, Loke SL,et al. Epstein-Barr virus is localized in the tumour cells of nasal lymphomas of NK, T or B cell type [ J ]. Int J Cancer, 1995,60(3 ) :315 - 320.
  • 10Kim GE, Koom WS, Yang WI, et al. Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophanotypic analysis[J]. Head & Neck,2004,26(7) :584 -593.

共引文献38

同被引文献24

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部